- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: acquired resistance NSCLC EGFR
Total 15129 results
-
Tianjin Medical University Cancer Institute and...RecruitingNon-small Cell Lung Cancer | EGFR Activating Mutation | EGFR-TKI Resistant Mutation | Cell Cycle DeregulationChina
-
Black Diamond Therapeutics, Inc.RecruitingNon-Small Cell Lung Cancer | NSCLC | Metastatic Lung Cancer | Metastatic Lung Non-Small Cell Carcinoma | EGF-R Positive Non-Small Cell Lung Cancer | Advanced Lung Carcinoma | EGFR-TKI Resistant Mutation | Advanced Non-Small Cell Squamous Lung Cancer | Epidermal Growth Factor Receptor C797S | Epidermal...Korea, Republic of, United States
-
First Affiliated Hospital of Zhejiang UniversityTerminatedNon Small Cell Lung CancerChina
-
Shanghai Chest HospitalCompleted
-
Guangdong Association of Clinical TrialsChia Tai Tianqing Pharmaceutical Group Co., Ltd.Unknown
-
Astellas Pharma Global Development, Inc.Terminated
-
Massachusetts General HospitalBoehringer Ingelheim; University of TexasCompletedNon-small Cell Lung Cancer | EGFR MutationsUnited States
-
Qingdao Central HospitalCompletedEGFR-TKI Resistant MutationChina
-
Groupe Français de Pneumo-CancérologieRecruitingMechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion (RESAMEX)Non-small Cell Lung Cancer | EGFR Exon 20 Insertion MutationFrance
-
Jair Bar, M.D., Ph.D.Not yet recruiting
-
Daping Hospital and the Research Institute of Surgery...Not yet recruitingNon Small Cell Lung Cancer | EGFR Gene Mutation | Non-small Cell Lung Cancer Stage IV | Non Small Cell Lung Cancer Stage IIIA
-
Intergroupe Francophone de Cancerologie ThoraciqueRecruitingNon Small Cell Lung Cancer | EGFR Activating Mutation | EGFR L858R | EGFR DEL19France
-
Second Xiangya Hospital of Central South UniversityThe First Affiliated Hospital of Nanchang University; Xiangya Hospital of Central... and other collaboratorsRecruitingLung Cancer, Non-small Cell | Circulating Tumor DNA | EGFR Gene Mutation | EGFR-TKI Resistant Mutation | Primary ResistanceChina
-
Yonsei UniversityNot yet recruiting
-
Sun Yat-sen UniversityRecruiting
-
The Netherlands Cancer InstituteAstraZenecaRecruitingOsimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed. (OSIRIS)Non-small-cell Lung CarcinomaNetherlands
-
Daping Hospital and the Research Institute of Surgery...Not yet recruitingEGFR T790M | Non-small Cell Lung Cancer Stage IV | Non-Small Cell Lung Cancer Stage IIIB
-
Daping Hospital and the Research Institute of Surgery...Not yet recruitingEGFR T790M | Non-small Cell Lung Cancer Stage IV | Non-Small Cell Lung Cancer Stage IIIB
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineCompletedLung Cancer | Lung Cancer Metastatic | Lung Adenocarcinoma | Lung Cancer Stage IV | Recurrent Lung Adenocarcinoma | Recurrent Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedLung Neoplasms | Lung AdenocarcinomaUnited States
-
University of CologneCompletedBronchial NeoplasmsSpain, Germany
-
Blueprint Medicines CorporationActive, not recruitingNeoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Neoplasms, Nerve Tissue | EGF-R Positive Non-Small Cell Lung... and other conditionsUnited States, Canada, Taiwan, Korea, Republic of, Singapore, Japan, United Kingdom, France, Netherlands, Spain
-
University College, LondonBoehringer IngelheimCompletedNon-small Cell Lung CancerUnited Kingdom
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore
-
Blueprint Medicines CorporationTerminatedNeoplasms | Respiratory Tract Diseases | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Neoplasms, Nerve Tissue | Non Small Cell Lung... and other conditionsUnited States
-
The Netherlands Cancer InstituteRoche Pharma AG; AstraZenecaTerminatedCarcinoma, Non-Small-Cell LungNetherlands
-
National Cancer Center, KoreaHoffmann-La RocheActive, not recruitingNSCLC Stage II | NSCLC, Stage IIIAKorea, Republic of
-
Amsterdam UMC, location VUmcTerminated
-
Geneplus-Beijing Co. Ltd.Shanghai Chest HospitalCompletedLung Neoplasms | Adenocarcinoma of Lung | Lung Cancer, Nonsmall Cell | Squamous Cell Lung CancerChina
-
Astellas Pharma Global Development, Inc.CompletedNon-Small-Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor MutationsUnited States
-
AstraZenecaMedpace, Inc.CompletedNon-small Cell Lung CancerUnited States, Canada
-
Astellas Pharma IncTerminatedNon-small Cell Lung CancerJapan, Korea, Republic of, Taiwan
-
Shenzhen People's HospitalUnknownNSCLC | Apatinib | EGFR-TKIChina
-
Hellenic Oncology Research GroupUnknownNon Small Cell Lung CancerGreece
-
Beijing Chest HospitalUnknown
-
Memorial Sloan Kettering Cancer CenterIncyte CorporationCompleted
-
First Hospital of Shijiazhuang CityUnknownCarcinoma | Non-small Cell Lung Cancer | Lung NeoplasmChina
-
David M. Jackman, MDBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's HospitalCompletedNon-small Cell Lung CancerUnited States
-
AstraZenecaTerminatedCarcinoma, Non-Small-Cell LungFrance, Spain, United Kingdom, China, Canada, Taiwan
-
Centre Francois BaclesseHoffmann-La Roche; Groupe Français de Pneumo-CancérologieTerminatedNSCLC Patients With EGFR Activating MutationFrance
-
China Medical University, ChinaGeneral Hospital of Shenyang Military Region; Shengjing Hospital; Liaoning Tumor... and other collaboratorsUnknownNon Small Cell Lung Cancer
-
Jianxing HeAstraZenecaUnknownNonsmall Cell Lung Cancer
-
Tianjin Medical University Cancer Institute and...Roche Pharma AGUnknownNon-small Cell Lung Cancer Stage IIIChina
-
Zhejiang Cancer HospitalUnknownNon-small Cell Lung Cancer | Aquired Resistance | EGFR TKIsChina
-
Memorial Sloan Kettering Cancer CenterCompletedUnresectable or Metastatic Non-small Cell Lung Cancer (NSCLC)United States
-
PfizerCompletedNon Small Cell Lung CancerUnited States, Australia
-
Kyowa Kirin Co., Ltd.CompletedNon-small-cell Lung CancerJapan
-
National OncoVentureHanmi Pharmaceutical Company LimitedCompletedIncreased Drug ResistanceKorea, Republic of
-
AstraZenecaParexelTerminatedNon Small Cell Lung CancerUnited States, Korea, Republic of
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer